Ocrevus
Ocrelizumab is used for adults with relapsing or primary progressive forms of multiple sclerosis.
Ocrevus Info
30mg/mL (10mL single-dose vial)
Indicated for adults with relapsing or primary progressive forms of multiple sclerosis
Initial 2 doses: 300 mg intravenously (IV) once; repeat dose 2 weeks later
Subsequent doses: 600 mg IV every 6 months
Ocrevus Side Effects
The most common side effects include:
- Ocrelizumab
- Upper and lower respiratory tract infections
- Infusion-related reactions
- Skin infections
- Decreased white blood cell counts
- Depression
- Cough
- Back pain
- Herpes virus-associated infections
- Diarrhea
- Swelling of extremities
- Pain in extremities
Patient Assistance Programs
There are several programs patients can sign up for that will assist in treatment costs:
Resources
To learn more about this treatment, browse the resources below.
Ready to get started?
Contact us to chat with one of our helpful scheduling specialists!